These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 17034506
41. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F. Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255 [Abstract] [Full Text] [Related]
49. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Merrill MM, Lane BR, Reuther AM, Zhou M, Magi-Galluzzi C, Klein EA. Urology; 2007 Aug; 70(2):294-8. PubMed ID: 17826492 [Abstract] [Full Text] [Related]
52. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients. May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O. J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719 [Abstract] [Full Text] [Related]
53. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L. Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720 [Abstract] [Full Text] [Related]
55. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy. Walz J, Chun FK, Klein EA, Reuther A, Graefen M, Huland H, Karakiewicz PI. Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223 [Abstract] [Full Text] [Related]